RecruitingNCT03142659

Evaluation and Management of Heart Failure Patients


Sponsor

Tel-Aviv Sourasky Medical Center

Enrollment

5,000 participants

Start Date

Jul 1, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

The investigator is trying to improving our knowledge in the treatment of HF patients, for the purpose of improving their quality of life and reducing hospitalizations. For achieving this the investigator would like to build a registry which will include all the HF patients going an evaluation in the Heart Failure unit or clinic in our facility,


Eligibility

Min Age: 18 YearsMax Age: 120 Years

Inclusion Criteria3

  • Age ≥18 years old
  • Patient evaluated in the Heart Failure unit or clinic in our facility.
  • Approved consent.

Exclusion Criteria1

  • \. Patients who haven't signed the informed consent in the prospective group.

Interventions

OTHERregistry-no intervention

registry-no intervention After filling the informed consent the patients will be evaluated for clinical history and physical examination by the nurse and a cardiologist. Then, the patients may perform the following test: ECG, Chest X-RAY, Blood test including: complete blood count, renal and liver function, electrolytes, thyroid function, cholesterol, glucose, Troponin and Brain Natriuretic Peptide


Locations(1)

Tel Aviv Medical Center

Tel Aviv, Israel

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03142659


Related Trials